Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.

Vocke CD, Ricketts CJ, Ball MW, Schmidt LS, Metwalli AR, Middelton LA, Killian JK, Khan J, Meltzer PS, Simonds WF, Merino MJ, Linehan WM.

Urology. 2019 Feb;124:91-97. doi: 10.1016/j.urology.2018.11.013. Epub 2018 Nov 16.

2.

Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma.

Vocke CD, Ricketts CJ, Merino MJ, Srinivasan R, Metwalli AR, Middelton LA, Peterson J, Yang Y, Linehan WM.

Genes Chromosomes Cancer. 2017 Jun;56(6):484-492. doi: 10.1002/gcc.22452. Epub 2017 Mar 31.

3.

Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.

Naik HB, Steinberg SM, Middelton LA, Hewitt SM, Zuo RC, Linehan WM, Kong HH, Cowen EW.

JAMA Dermatol. 2015 Oct;151(10):1096-102. doi: 10.1001/jamadermatol.2015.1793.

PMID:
26244563
4.

Comedonal and Cystic Fibrofolliculomas in Birt-Hogg-Dube Syndrome.

Aivaz O, Berkman S, Middelton L, Linehan WM, DiGiovanna JJ, Cowen EW.

JAMA Dermatol. 2015 Jul;151(7):770-4. doi: 10.1001/jamadermatol.2015.0215.

PMID:
25970555
5.

Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.

Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittomäki K, Tomlinson I, Richard S, Linehan WM.

Fam Cancer. 2014 Dec;13(4):637-44. doi: 10.1007/s10689-014-9735-2. Review.

6.

Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer.

Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM.

J Urol. 2013 Dec;190(6):1990-8. doi: 10.1016/j.juro.2013.06.012. Epub 2013 Jun 11.

7.

A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.

Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J.

Mol Cancer Res. 2013 Sep;11(9):1061-1071. doi: 10.1158/1541-7786.MCR-13-0111. Epub 2013 May 24.

8.

Diagnosis and management of BHD-associated kidney cancer.

Stamatakis L, Metwalli AR, Middelton LA, Marston Linehan W.

Fam Cancer. 2013 Sep;12(3):397-402. doi: 10.1007/s10689-013-9657-4. Review.

9.

Birt-Hogg-Dubé: beyond the clinical manifestations.

Middelton LA.

Fam Cancer. 2013 Mar;12(1):97-9. doi: 10.1007/s10689-012-9583-x. Erratum in: Fam Cancer. 2013 Sep;12(3):403.

10.

Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.

Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM.

J Urol. 2012 Dec;188(6):2063-71. doi: 10.1016/j.juro.2012.08.030. Epub 2012 Oct 18.

11.

Impact of genetics on the diagnosis and treatment of renal cancer.

Singer EA, Bratslavsky G, Middelton L, Srinivasan R, Linehan WM.

Curr Urol Rep. 2011 Feb;12(1):47-55. doi: 10.1007/s11934-010-0156-y.

12.

Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome.

Kluijt I, de Jong D, Teertstra HJ, Axwijk PH, Gille JJ, Bell K, van Rens A, van der Velden AW, Middelton L, Horenblas S.

Clin Genet. 2009 Jun;75(6):537-43. doi: 10.1111/j.1399-0004.2009.01159.x. Epub 2009 Mar 23.

PMID:
19320655
13.

Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).

Blansfield JA, Choyke L, Morita SY, Choyke PL, Pingpank JF, Alexander HR, Seidel G, Shutack Y, Yuldasheva N, Eugeni M, Bartlett DL, Glenn GM, Middelton L, Linehan WM, Libutti SK.

Surgery. 2007 Dec;142(6):814-8; discussion 818.e1-2. Erratum in: Surgery. 2008 Feb;143(2):302.

14.

Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.

Grubb RL 3rd, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM.

J Urol. 2007 Jun;177(6):2074-9; discussion 2079-80.

PMID:
17509289
15.

Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.

Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, Coleman J, Pinto P, Schmidt LS, Choyke P, Linehan WM.

J Urol. 2007 Feb;177(2):461-5; discussion 465.

PMID:
17222609
16.

Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.

Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR.

J Med Genet. 2006 Jan;43(1):18-27. Epub 2005 Jun 3.

17.

Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.

Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS, Warren MB, Choyke PL, Torres-Cabala CA, Merino MJ, Brunet J, Bérez V, Borràs J, Sesia G, Middelton L, Phillips JL, Stolle C, Zbar B, Pautler SE, Linehan WM.

J Urol. 2004 Oct;172(4 Pt 1):1256-61.

PMID:
15371818
18.

Portfolio evaluation for professional competence: credentialing in genetics for nurses.

Cook SS, Kase R, Middelton L, Monsen RB.

J Prof Nurs. 2003 Mar-Apr;19(2):85-90.

PMID:
12748933
19.

Inherited urologic malignant disorders: nursing implications.

Middelton L, Lessick M.

Urol Nurs. 2003 Feb;23(1):15-8, 23-9; quiz 30.

PMID:
12677717
20.

The role of the nurse in cancer genetics.

Middelton L, Dimond E, Calzone K, Davis J, Jenkins J.

Cancer Nurs. 2002 Jun;25(3):196-206. Review.

PMID:
12040228
21.

Genes and inheritance.

Middelton LA, Peters KF.

Cancer Nurs. 2001 Oct;24(5):357-69; quiz 369-70. Review.

PMID:
11605706
22.

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.

Jackson CE, Fischer RE, Hsu AP, Anderson SM, Choi Y, Wang J, Dale JK, Fleisher TA, Middelton LA, Sneller MC, Lenardo MJ, Straus SE, Puck JM.

Am J Hum Genet. 1999 Apr;64(4):1002-14.

23.

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.

Infante AJ, Britton HA, DeNapoli T, Middelton LA, Lenardo MJ, Jackson CE, Wang J, Fleisher T, Straus SE, Puck JM.

J Pediatr. 1998 Nov;133(5):629-33.

PMID:
9821419
24.
25.

Genes and inheritance.

Middelton LA, Peters KF, Helmbold EA.

Cancer Nurs. 1997 Apr;20(2):129-47; quiz 148-51. Review.

PMID:
9145562
26.

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, Lim MS, Jaffe ES, Puck JM, Lenardo MJ, Straus SE.

Blood. 1997 Feb 15;89(4):1341-8.

PMID:
9028957
27.

Labor complicated by rectal stricture.

POSNER LB, MIDDELTON LV, POSNER AC.

Obstet Gynecol. 1955 Oct;6(4):430-3. No abstract available.

PMID:
13254055

Supplemental Content

Loading ...
Support Center